Clinical Trial Update: Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atomoxetine for prevention of vasovagal syncope has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasovagal Syncope

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: University of Calgary | Conditions: Vasovagal Syncope | Phase 2 | Status: COMPLETED | Results posted: 2020-04-21